54
https://pubmed.ncbi.nlm.nih.gov/38117468
The DIANA-5 trial found that a Mediterranean-macrobiotic diet did not affect 5-year breast cancer recurrence, but high adherence was associated with reduced recurrence risk, and the impact of substantial weight loss on prognosis remains unclear.